Ann: Dr Philip Sutton - V.P. of Translational Sciences, page-12

First 12 Last

Share
Profile

Follow
BobF

2,679 Posts.

2816

20/07/22

12:17

Post #: 62627847
Share

Originally posted by lonade: ↑

Sitight,

all the things you stating are things that you would like to happen. You want the company to be successful and make a profit one day.
Fair enough, I wouldn't be here if I wouldn't want the same and have the same conviction that it will come to that in the near future.
The company has been processing well in its indications, I also agree.

But, what someone has done for someone else is irreverent from a financial perspective. This new addition needs to prove that he can advance the company and show that his efforts that have made a change. He is currently an investment that needs to show he can bring the returns to the company.

We are on the same page, I just expect someone do to something noteworthy for Recce before judging if he was a good addition or not.

Credentials are good no doubt about that, so let's wait for the upcoming NR's on all those new indications progressing to next stages.

Expand

What criteria you intend to use to track whether his input achieves your expectations before you grant him some slack to get on with the job the experts in the company believe he can deliver?

RCE Price at posting: 77.5¢ Sentiment: Hold Disclosure: Held
3 Upvote

1 Great analysis

Reply

Top Stories

NUZ

Neurizon inks $1.5M loan against R&D Tax Rebate

HAR

Haranga jumps +7% on Lincoln acquisition

IXR

Ionic Rare Earths falls -7% as momentum slips on vague production update

ASX Market Close: Index rebounds as investors buoyant | July 30, 2025

HotCopper Trends: Wall of quarterlies dominate; then there's Micro-X & Ionic

First 12 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 38.5¢		Change -0.005(1.28%)		Mkt cap ! $111.3M

Open	High	Low	Value	Volume
38.5¢	38.5¢	37.0¢	$21.54K	57.86K

Buyers (Bids)

No.	Vol.	Price($)
1	3248	37.5¢

Sellers (Offers)

Price($)	Vol.	No.
39.0¢	49884	1

View Market Depth

No.	Vol.	Price($)
1	3248	0.375
1	2000	0.370
3	38185	0.365
2	71806	0.360
2	85000	0.355

Price($)	Vol.	No.
0.390	49884	1
0.400	23104	2
0.410	25471	1
0.440	8669	2
0.450	20976	3

Last trade - 14.27pm 30/07/2025 (20 minute delay)

RCE (ASX) Chart

Ann: Dr Philip Sutton - V.P. of Translational Sciences, page-12

Neurizon inks $1.5M loan against R&D Tax Rebate

Haranga jumps +7% on Lincoln acquisition

Ionic Rare Earths falls -7% as momentum slips on vague production update

ASX Market Close: Index rebounds as investors buoyant | July 30, 2025

HotCopper Trends: Wall of quarterlies dominate; then there's Micro-X & Ionic

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Dr Philip Sutton - V.P. of Translational Sciences, page-12

Top Stories

Neurizon inks $1.5M loan against R&D Tax Rebate

Haranga jumps +7% on Lincoln acquisition

Ionic Rare Earths falls -7% as momentum slips on vague production update

ASX Market Close: Index rebounds as investors buoyant | July 30, 2025

HotCopper Trends: Wall of quarterlies dominate; then there's Micro-X & Ionic

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News